What they found (summary): NAD+ is the integrator of metabolic and stress signals The decline in NAD+ with age is a causal factor , not merely a correlation PARP and CD38 are the main consumers of NAD+ in aging cells Selective CD38 inhibitors are a new therapeutic option NAD+ has potential in neurodegeneration (Alzheimers, Parkinsons, ALS) Why it matters: Verdins review in Science gave the NAD+ field academic prestige
Continual extensive and ongoing research seeks to learn more about PD in order to better definitively diagnose the disease, diagnose the disease as early as possible, and to provide more effective treatment
B.TurnerC
Patients notice better sleep, less brain fog, radiant skin, and greater energy after one treatment
Acetaminophen use may also affect attention
Pharmacologically, BPC-157 exhibits rapid absorption following administration, with studies in rats and dogs indicating a half-life of less than 30 minutes after intravenous or intramuscular delivery